earnings
confidence high
sentiment positive
materiality 0.80
Cencora Q2 FY2025 revenue $75.5B (+10.3% YoY); adj. EPS $4.42 (+16.3%); raises FY guidance
Cencora, Inc.
2025-Q2 EPS
reported $6.18
vs consensus $3.88
▲ beat
(+59.4%)
- Revenue $75.5B, +10.3% YoY; GAAP diluted EPS $3.68 vs $2.09 prior year.
- Adjusted diluted EPS $4.42, up 16.3% from $3.80; adjusted net income $863M.
- FY2025 adjusted diluted EPS guidance raised to $15.70-$15.95 from $15.30-$15.60.
- CEO Robert Mauch highlights strength of value proposition and pharmaceutical distribution.